and hereditary nonpolyposis colorectal cancer (HNPCC) [2, 3] . In terms of environmental causes, food refrigeration has probably reduced the dietary exposure to various carcinogens, such as nitrates and nitrites, by reducing the bacterial and fungal contamination of food. Refrigeration has also reduced the consumption of smoked, cured, and salted foods, thereby reducing the incidence of intestinal-type gastric cancer. Fruits and vegetables are known to be protective against gastric cancer carcinogenesis, while a modest increase in risk has been reported for increased meat consumption, with a positive correlation with longer cooking times. Other environmental factors, such as smoking or industrial dust exposure, may also be associated with gastric cancer. Chronic infections of the stomach by H. pylori or Epstein-Barr virus have been reported in epidemiological studies, and a relationship between chronic infection and gastric carcinogenesis has been suggested [4] .
The Unitarian hypothesis and cell lineages in the gastrointestinal (GI) tract
The most popular concept of tissue regeneration in the GI tract is the Unitarian hypothesis, in which a single stem cell gives rise to all cell lineages in the epithelium ( Fig. 1 ) [5] [6] [7] [8] [9] . Holzer's concept that pluripotentiality can be the property of only a group of cells rather than a single cell has led to the proposal of "committed progenitor cells" [10] , but ultimately, all cell lineages might originate from a single cell. Only recently, various investigators have obtained defi nitive evidence for the existence of such committed progenitors in the intestinal epithelium [8] [9] [10] [11] . The main evidence for the Unitarian hypothesis was the fi nding of radiolabeled debris in all cell lineages in the small-intestinal epithelium after a minimum dose of isotope (tritiated thymidine) that killed only basal crypt cells which were phagocytosed by adjacent surviving stem cells [12] . However, reservations have been raised about the proposal of committed progenitor cells [13] , including questions about the selective phagocytic ability of crypt base cells. Moreover, conclusions about the endocrine cell lineage were confi ned to the fi nding of nonradioactive debris in a single endocrine cell, perhaps scant basis for such a defi nitive conclusion. However, all cell lineages are present in colonies of intestinal cells regenerating after irradiation [14] . In addition, mouse fundic stomach mucosa, autotransplanted to subcutaneous tissue, is colonized by a layer of simple immature mucosal cells, which gives rise to parietal, mucous neck, and argyrophil cells, with eventual reconstitution of the gastric mucosa [15] . In the acid-secreting gastric mucosa, classical continuous and fl ash labeling methods with tritiated thymidine have shown that undifferentiated "granule-free" cells located in the isthmus of the gland are self-renewing and give rise to all lineages in the gastric tubule via three committed precursors -the prepit cells, the preparietal cells, and the preneck cells, with the peptic or zymogenic cell as the end-stage differentiated progeny of the neck cells [7] . A recent review by Wright [11] has suggested that the intestinal stem cell has a repertoire which includes all the main cell lineages within the intestinal crypt systems. In addition, the stem cell can derive reparative lineages in appropriate situations, can produce new crypts, and can even give rise to GI carcinomas [10] .
Stem cells and normal epithelial cell lineages in the stomach
The epithelial cell lineages of the stomach undergo constant turnover, with complete self-renewal every 2 to 7 days under normal circumstances, while cell turnover is enhanced by tissue damage [16] . Wright [11] proposed the concept of intestinal stem cells and cell lineages, and the same system can be extended to the gastric mucosa. Thus, it is believed that there is a hierarchical system of proliferating and differentiated cells generated by multipotent stem cells. Those stem cells remain unidentifi ed in a distinct "niche", their highly primitive nature resulting in a lack of any defi nitive phenotypic or morphological markers. Recent studies of the mouse stomach have demonstrated that three classes of progenitor cells (prepit, preneck, and preparietal cells) are derived from multipotent granule-free cells in the isthmus region [17] .
Other studies have demonstrated useful markers for stem cells [18] [19] [20] . Several reports suggest that progenitor cells are present in normal human gastric mucosa, and that gastric stem cells are present in the proliferative zone of the neck/isthmus region, giving rise to all the differentiated epithelial cell types [18] . A previous study has demonstrated that Musashi-1 (Msi-1) is a useful marker for mouse intestinal stem cells [19] . Msi-1 has been identifi ed on progenitor cells in gastric mucosa in the neck/isthmus [20] (Fig. 2) . In differentiation, cells derived from stem cells undergo a complex bipolar migration from the neck/isthmus region, moving either upward or downward. Helicobacter pylori infection modifi es the distribution and migration of cells derived from the neck/isthmus region [21] .
Defi nition of cancer stem cells (CSCs)
Interest in gastric cancer stem cells (CSCs) has arisen in the broader context of the CSC hypothesis, which fi rst appeared more than a century ago when European pathologists observed that tumors were composed of a heterogeneous mixture with partially differentiated cell types, similar in many respects to a normal organ [22, 23] . Dick's laboratory group (Lapidot et al. [24] and Bonnet and Dick [25] ) fi rst demonstrated the existence of CSCs more than a decade ago, when they proved the CSC hypothesis in human acute myeloid leukemia. The leukemic stem cell, which was defi ned by the CD34+/ CD38− immunophenotype, serially reproduced the disease in nonobese diabetic/severe combined immunodefi ciency (SCID) mice. The leukemic CSCs were remarkably long-lived and possessed self-renewal capacity. Thus, the growth of specifi c tumor cells with defi ned markers in immunodefi cient mice has become the gold standard for identifying CSCs [26] in breast cancer [27] , brain cancer [28] , prostate cancer [29] , melanoma [30] , colon cancer [31] [32] [33] , liver cancer [34] , [38] . Accumulating data support the hypothesis that CSCs exist in many solid tumors, though little evidence has been reported for gastric CSCs [21, 39] . Recently, the term "tumorinitiating cells" (TICs) has been adopted in experimental studies instead of "CSCs", indicating the uncertainty associated with the CSC hypothesis ( Fig. 3) . Several experimental procedures have been used to identify CSCs or TICs [39] [40] [41] . An in vitro method termed "spheroid colony formation," involves growing candidate CSCs in culture dishes specially coated with adhesion molecules in serum-free medium containing only epidermal growth factor and basic fi broblast growth factor. The growth of spherical colonies after a few weeks suggests self-renewal ability consistent with a CSC phenotype. An in vivo method involving the implantation of candidate CSCs under the skin or within organ-specifi c sites (e.g., orthotopic) of SCID or NOD/ SCID/interleukin receptor (ILR)γ null (NOG) mice is generally regarded as the standard method for proving true tumorigenicity and the existence of CSCs (Fig. 4) . In a third methodology, fl ow cytometric isolation of "side population" (SP) cells, fi rst described by Goodell et al. [42] , permits the enrichment of cells with stem cell activity and distinctive expression of the ATP-binding cassette (ABC) transporters. SP cells are reportedly enriched in primitive, nondifferentiated cells [43, 44] , and recent studies have shown the existence of SP cells in human solid cancers [39, [45] [46] [47] [48] [49] (Fig. 5 ). Many studies have already suggested that the SP fraction is an enriched fraction for TICs.
Using the above-mentioned procedures, investigators have reported the possible existence of CSCs or TICs in solid malignant tumors [40, 41] . Thus, solid cancers can be viewed as differentiated cells, such that only CSCs are able to sustain and propagate the tumors and give rise to invasive lesions and metastases. This new paradigm may enable us to establish novel approaches to cancer therapy targeted against CSCs. Presumably, the eradication of non-CSCs will be somewhat easier [48] . (Table 2) While markers specifi c for NSCs have been identifi ed in several human tissues, reliable makers for NSCs in
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High magnification [19, 20] , and serves as a marker for progenitor cells in the human stomach. Msi-1+ cells were detected immunohistochemically in the isthmus/neck region (the putative location of stem cells) of the adult antrum. Msi-1+ cells were intermingled with proliferating cell nuclear antigen (PCNA) + cells in the isthmus/neck region of the adult antrum, but did not coexpress PCNA or Ki 67 [20] . Msi-1 expression overlapped partly with the expression of MUC 5 and MUC 6, indicating that Msi-1+ cells retain some features of both foveolar and pyloric gland cell differentiation phenotypes [20] , and suggesting that Msi-1 might be a marker of cells with progenitor characteristics before active proliferation in the human antrum. Takaishi et al. [21] recently identifi ed gastric cancerinitiating cells from a panel of human gastric cancer cell lines, using the cell surface marker CD44. They isolated and analyzed subpopulations of CD44(+) TICs from MKN-45, MKN-74, and NCI-N87 lines, characterizing spheroid colony formation, and tumorigenic ability in the stomach and skin of SCID mice. The study by Takaishi et al. [21] demonstrated that SP cells isolated by fl ow cytometric sorting did not include TICs. However, our previous study demonstrated that the SP fraction of MKN-45 cells had sphere-forming ability and high tumorigenicity in NOD mice, resistance to anticancer drugs, and an immunophenotype similar to that of stem cells [39] . The inconsistencies between these two studies require further analysis. However, the possibility remains that established gastric cancer cell lines maintain a specifi c population of TICs or CSCs.
NSCs and CSCs: microenvironmental niches
The microenvironment surrounding stem/progenitor cells in the isthmus/neck region contributes to the maintenance of stem/progenitor cells, the regulation of cell numbers, and the directing of differentiation. Important microenvironmental factors likely include threedimensional intercellular relationships, vascular/lymphatic factors, cytokines, immune factors, tissue O 2 /CO 2 pressure, and stem/progenitor cell dynamics. The microenvironmental stem cell compartment is termed the "niche" and it maintains optimal conditions for cells with stem cell capacity [50] [51] [52] . In the GI epithelial stem cell niche, the underlying cells of the mesenchymal lamina propria probably regulate stem cell behavior through secreted basement membrane factors and the paracrine secretion of various growth factors and cytokines, the receptors for which are situated on GI epithelial cells [50] . The detailed properties of the niche in the gastric isthmus/neck region are still under investigation [51] .
The mechanism by which the microenvironment of the stem cell niche maintains both stem cell renewal and differentiative capacity is unclear [52] [53] [54] [55] [56] [57] [58] [59] . Using GFPexpressing neural stem cells [52] or GFP-expressing bone marrow stem cells (BMSCs) [53] , several studies have suggested fusion with embryonic stem (ES) cells was important. However, these phenomena were observed using genetically artifi cial ES cells in culture, and seemed not to be the same as the in vivo observations of adult stem cell plasticity. These fusion events were too infrequent to account for reported BMSC plasticity in vivo, as only 2-11 hybrid clones were formed per 10 6 BMSCs [53] , while 6 weeks after BMSC transplantation, almost 60% of intestinal SP analysis Side population (SP) analysis using gastric cancer cell lines. The existence of SP cells in human gastric cancer has been confi rmed, and many studies suggest that the SP cell fraction derived from a tumor in solid cancers will be enriched for TICs subepithelial myofi broblasts in the normal mouse colon were derived from the transplanted cells. Thus, the underlying mechanism supporting stem cell renewal and differentiation inside the niche remains a critical question in understanding the NSC's capacity for generating multiple cell lineages in a tissue [55] [56] [57] [58] [59] . Complete understanding of such phenomena might greatly assist the development of new treatment modalities for solid malignant tumors.
Contribution of bone marrow stem cells (BMSCs) to normal gastric cell lineages and gastric carcinogenesis
Every tissue consists of normal differentiated cells derived from undifferentiated stem cells. Morphological identifi cation of stem cells in each tissue is diffi cult due to the paucity of lineage-specifi c phenotypic markers. Stem cells can upregulate cell turnover in response to increasing regenerative demand evoked by tissue damage or disease. During stem cell production of the entire specialized cell repertoire of the stomach, they must maintain a balance between self-renewal and the rapid differentiation of committed cells, and their proliferation, senescence, and apoptosis. Certain adult stem cells give rise to multiple cell lineages within foreign tissues, a phenomenon termed "plasticity" or "transdifferentiation". For example, transplanted adult BMSCs contribute to several nonhematopoietic lineages, including epithelial and mesenchymal lineages in the mouse and human GI tract [60] [61] [62] [63] [64] . Bone marrow-derived cells (BMDCs) are thought to be the most primitive uncommitted adult stem cells, and they possess differentiative capacity similar to that of BMSCs, possessing a wide range of plasticity and ability to migrate through peripheral organs following infl ammation and tissue injury. The differentiative pattern and growth regulation of BMDCs or BMSCs may well depend largely on local environmental signals and cues [62, 65, 66] .
These principles have been demonstrated in the fumarylacetoacetate hydrolase (FAH-/-)-defi cient mouse, which develops a fatal metabolic liver disease resembling human type I hereditary tyrosinemia. The mouse can be rescued by transplantation of hematopoietic BMSCs, which migrate to the liver and differentiate into FAH-synthesizing hepatocytes [67] . In addition, lethally irradiated female mice injected with a single male hematopoietic BMSC demonstrated donorderived epithelial cells in the esophagus, stomach, small intestine, and colon 11 months after transplantation [64] . In patients who received a peripheral blood stem cell transplant, epithelial cells of donor origin were observed throughout the GI mucosa [64] . In GI biopsies from female patients who suffered graft versus host disease following a bone marrow transplant from a male donor, transplanted BMSCs contributed to a population of myofi broblast cells, the intestinal subepithelial myofi broblasts (ISEMF). These cells are located in the lamina propria subjacent to the epithelial mucosa and regulate intestinal epithelial cell function via epithelial/ mesenchymal interactions. Transplanted BMSCs contribute to ISEMFs in both the mouse and human small intestine and colon, and 6 weeks post-transplant, almost 60% of all ISEMFs in the mouse colon were of donor origin [62] . Transplanted BMSCs also transdifferentiate to form fi broblasts and smooth muscle cells in the lamina propria and mucosal layers, indicating that transplanted adult BMSCs contribute to multiple specialized adult GI mesenchymal lineages in diseased tissue. Additionally, perivascular smooth muscle cells and endothelial cell lineages derived from transplanted cells were observed in newly formed blood vessels in infl amed colons, suggesting a potential role of transplanted BMSCs in vasculogenesis. It is possible that a bone marrow cell might differentiate into a myofi broblast stem cell, and this highlights the potential for bone marrow cells as regulators of epithelial cell function via mesenchymal-epithelial paracrine interactions. These results substantiate the importance of the adult BMSC in the treatment of human infl ammatory disease, and suggest that bone marrow cells might contribute to multiple cell lineages in the regeneration of the GI tract. Detailed information regarding tissue regeneration and clonal expansion of BMSCs is currently lacking for the GI tract. Further investigations into the mechanisms of adult stem cell transdifferentiation and the origins of both epithelial and mesenchymal lineages in the GI tract may enhance our understanding of the biological mechanisms of normal GI system function, including the genetic and epigenetic regulation of events via cellular signaling pathways in nonmalignant and malignant diseases.
Houghton et al. [4] demonstrated in 2004 that BMDCs might also represent a potential source of malignant cells in gastric cancer, while epithelial cancers are believed to originate from the transformation of tissue stem cells. Normal BMDCs are frequently recruited to sites of tissue injury and infl ammation. Houghton et al. [4] showed that chronic infection of C57BL/6 mice with Helicobacter induced repopulation of the stomach with BMDCs, and subsequently these cells progressed through metaplasia and dysplasia to intraepithelial cancer. These fi ndings suggest that epithelial cancers can originate from marrow-derived sources. These data have broad implications for the multistep model of cancer progression [4] . Subsequently, many studies (described below) demonstrated the possible relationship of BMDCs to carcinogenesis [68, 22] . Previous studies showed that bone marrow-derived endothelial progenitor cells can contribute directly to angiogenesis in tumor formation [67] [68] [69] [70] [71] . In addition, BMDCs may indirectly infl uence carcinogenesis as cancer-associated fi broblasts [72, 73] . Bone marrow-derived human mesenchymal stem cells may increase the metastatic potency of human breast cancer by stimulation of the de novo secretion of the chemokine CCL5 [74] . Houghton et al. speculated that the plasticity of BMDCs might contribute to epithelial cancers, particularly those associated with chronic infl ammation [4] . The model of gastric cancer in Helicobacter felis-infected C57BL/6 mice represents an ideal system for evaluating the effects of chronic infl ammation on BMDC recruitment and engraftment in the stomach. In this model, infl ammation is maximal 2 to 3 months after infection, and the infl ammation subsequently continues at a moderate level for the remainder of the life of the animal. With persistent Helicobacter infection, the gastric mucosa progresses through a series of dramatic changes, including metaplasia and dysplasia, and ends in invasive gastric cancer after 12 to 18 months of infection [75] [76] [77] . In this model, chronic infl ammation and tissue injury may be associated with BMDC engraftment within the gastric epithelium, and this environment is also strongly linked with the progression of infl ammation-associated cancer. BMDCs may also contribute to established cancers through cell mimicry or cell fusion, or they may initiate cancer directly. Recent studies have suggested that cell fusion is a possible mechanism for bone marrow-derived hepatocytes or intestinal cells [78] [79] [80] [81] [82] . Interestingly, acute gastric infection with Helicobacter species, acute ulceration, or drug-induced parietal cell loss does not lead to the recruitment of BMDCs, while severe chronic infl ammation may lead to BMDC-related carcinogenesis. The latter process probably upregulates proinfl ammatory cytokines such as IL-1β, IL-6, and tumor necrosis factor-α (TNFα), and chemokines such as CXCL12 (also known as SDF-1α), contributing to the recruitment of progenitors. Recent studies have also shown that activated myofi broblasts (alpha smooth muscle actin [α-SMA]-expressing stromal cells) could be a source of CXCL12, mediating progenitor recruitment [83, 84] . In addition, in 2008, Oguma et al. [85] demonstrated that TNFα, derived from recruited macrophages, potentiated Wnt/beta-catenin signaling and gastric carcinogenesis by activating Akt signaling and GSK3beta phosphorylation independent of the nuclear factor (NF)-kappaB pathway in activated epithelial cells.
In summary, these observations suggest that Helicobacter-mediated chronic infl ammation regulates the "penetrance" of initiating oncogenic mutations in the GI tract, leading to GI carcinogenesis.
Signaling pathways regulating the differentiation of NSCs
Recent developments are improving our understanding of the molecular pathways that regulate the proliferation and differentiation of stem cells to mature GI cells. Several major signal transduction pathways such as Wnt/β-catenin, the T-cell factor/lymphocyte enhancer factor (Tcf/LEF) DNA binding protein family, the Cdx-1 and Cdx-2 homeobox genes, transforming growth factor (TGF)-β, and Smad, Notch, and sonic hedgehog have already been reported to modulate cell proliferation and differentiation. However, our understanding is incomplete. Below, several pathways are discussed in regard to epithelial cell proliferation and differentiation, in both normal and neoplastic GI mucosa, as determined by the stem cell niche/ microenvironment.
The Wnt/β-catenin pathway is a major contributor to malignant transformation, as 85% of human sporadic colorectal tumors are reported to have an APC mutation [86] . This APC mutation renders the GSK3β/Axin/ APC complex incapable of destabilizing β-catenin, thereby leading to an accumulation of nuclear β-catenin/ Tcf/LEF complexes, and a subsequent increase in target gene transcription and cell proliferation which can lead to tumor formation [87, 88] . The Wnt protein activates the cytoplasmic phosphoprotein through its receptor "frizzled", causing inhibition of GSK3β and a resultant accumulation of cytosolic β-catenin [89] . The β-catenin then translocates to the nucleus and interacts with the Tcf/LEF family of DNA binding proteins, converting them from transcriptional repressors to activators. This step activates downstream target genes with carcinogenic potential in the GI tract, such as c-myc, tcf-1, cyclin D1, c-jun, urokinase-type plasminogen activator receptor, fi bronectin, CD44, or the matrix metalloproteinase matrilysin [87] [88] [89] [90] . When the Wnt signal is removed, APC extracts β-catenin from the nucleus, and Tcf/LEF activation is suppressed [91] . The Tcf/LEF DNA binding protein family consists of four proteins: Tcf-1, LEF1, Tcf-3, and Tcf-4. They are essential in establishing the stem cell population within the niche of small-intestinal crypts, and are likely activated by Wnt signaling from the underlying mesenchymal cells which form the stem cell niche [91] . The mammalian homeobox proteins Cdx-1 and Cdx-2 also appear to play an important role in intestinal epithelial stem cell transcriptional regulation [92] [93] [94] [95] [96] . The TGF-β family (TGF-β and Smad) and notch signaling may also regulate GI epithelial cell proliferation or differentiation [97] [98] [99] [100] [101] [102] .
The sonic hedgehog (Shh) pathway provides important signals in gastric cell differentiation. The SHH gene encodes a morphogenetic signaling protein with an important regulatory role in GI development [103] . Gastric epithelial cells in the stomachs of both adult mice and humans express high levels of Shh. This observation has led to proposals that Shh promotes gland cell differentiation with negative regulation of progenitor cell and gland cell proliferation [104, 105] . Mice with a targeted homozygous deletion of Shh fail to develop gastric epithelium, resulting in mucosal defects [106] . Fox1 is thought to be a downstream target of the Shh signaling pathway, as verifi ed by its inhibition by bone morphogenetic protein 4 (BMP4), a member of the TGF-β superfamily [107] . When Shh signaling in mice was blocked with cyclopamine, increased gastric gland cell proliferation and levels of expression of the Shh receptor "patched" (Ptc) were observed. Furthermore, transcriptional targets of Shh (transcription factor HNF3β [FOX2a], BMP4, and islet factor-1 [ISL1]) were decreased [103] . In the mouse, Shh, Ptc, HNF3β, and BMP2 are expressed within gastric epithelial cells [104, 105] , whereas Fox1 and BMP4 are expressed in myofi broblasts [105, 107] , providing further evidence of epithelial-mesenchymal interactions in the regulation of GI cell proliferation and differentiation. The observed negative regulation of epithelial cell proliferation by Shh was unexpected, as Shh generally increases cell proliferation [107] . However, BMPs are known inhibitors of cell proliferation, and the observed increase in proliferation when Shh signaling is blocked with cyclopamine could result from the downstream inhibition of BMP4.
The GATA family of transcription factors is important in the development of many endodermal structures in a variety of organisms. GATA-4 is vital for gastric epithelial morphogenesis, as mice with a targeted homozygous deletion of the GATA4 gene show defects in gastric gland morphogenesis and fail to form terminally differentiated adult epithelial gastric lineages. The increased expression of Shh in the gastric epithelial cells of these mice indicates that GATA-4 interacts with Shh to regulate epithelial cell proliferation [108] .
Clinical signifi cance of stem cell research in the fi eld of solid cancers
Here, we focus on four clinical aspects: (1) recurrent disease and CSCs, (2) chemoresistance of CSCs, (3) prognostic outcome after surgical therapy or chemo-(radio) therapy, and (4) novel therapeutic approaches.
Considering tumor recurrence, even after curative surgery with complete resection of the tumor, as proven by histological investigation, recurrent disease with local or metastatic lesions may be found after surgery. On the contrary, even after noncurative surgery with residual cancer cells, as proven by histological investigation, the treatment may result in a curable outcome without regrowth of the tumor at the lesion. Thus, relapse is likely due to CSCs, which can survive in local or distant organs, forming one or more tumors even after curative surgery. Considering metastasis, the survival of metastasizing epithelial cancer cells is diffi cult because blood and lymphatic fl uid do not supply an appropriate microenvironment. With regard to BMDCs and BMSCs, epithelial cell metastasis may involve a mesenchymal-epithelial transformation of CSCs with self-renewal and differentiation. This would enable CSCs to migrate through the hematogenous or lymphatic system, survive for several years, and regrow at a local site or distant organ.
The treatment of solid tumors is made diffi cult by CSCs' chemoresistance. Two mechanisms of resistance are recognized: inherent and acquired resistance to anticancer drugs. CSCs are known to overexpress ABC transporter genes such as MDR1 [109] [110] [111] [112] and BCRP1 [113] [114] [115] , suggesting that CSCs themselves are more chemoresistant to anticancer drugs than mature cancer cells (Fig. 6) . Thus, the chemosensitivity of a tumor cell might be determined by the number of CSCs within the tumor, even before or after exposure to therapeutic drugs.
Following treatment, it is not possible to predict the outcome, as some patients will be cured while others will relapse. Those who achieve complete cure likely had all CSCs eliminated by therapy and/or surgery (Fig.  7) . And, even a small population of CSCs might mean cancer recurrence to death, while the mature cancer cells cannot survive in inappropriate microenvironments such as the peritoneum, hematogenous or lymphatic system, or other organs.
According to novel therapeutic approaches, Bao et al. [116] reported that glioblastoma stem cells were generally resistant to radiation therapy, but that such radioresistance could be reversed with a specifi c inhibitor of Chk1 and Chk2 checkpoint kinases. Piccirillo et al. [117] utilized BMP4, which can trigger a signifi cant reduction in the stem-like, tumor-initiating precursors of human glioblastomas, effectively suppressing tumor growth and reducing mortality in mice after the intracerebral grafting of human glioblastoma cells. These new therapies targeting brain CSCs may be applicable to other CSCs, including gastric cancer.
Conclusion
CSCs are defi ned as a unique subpopulation in tumors which possesses the ability to initiate tumor growth and sustain self-renewal as well as having metastatic potential. Evidence strongly indicates the existence of At the initiation of cancer treatment, the outcome cannot be predicted. CSC theory suggests that curative treatment requires complete elimination of CSCs by means of surgery or chemo-(radio) therapy (CTx). Even a small residual population of CSCs greatly increases the chance of relapse. The greater the number of CSCs in a tumor, the greater the diffi culty in achieving a cure CSCs in solid tumors in a wide variety of organs, including gastric cancer. The origin of human gastric CSCs has yet to be elucidated, but data obtained from a mouse model of Helicobacter-induced gastric cancer have implicated BMDCs as a potential candidate. These novel fi ndings will lead to new insights in infl ammation-associated cancers of every organ, including the hierarchy ranging from CSCs down to mature gastric cancer cells. Although most recent cancer research and therapeutic modalities consider tumors as a mass of comparatively homogeneous cells, it is important to recognize tumor heterogeneity and seek a therapeutic approach for targeting CSCs. Further studies focused on the identifi cation and characterization of CSCs in gastric cancer may lead to novel diagnostic and therapeutic tools, dramatically improving the prognosis of gastric cancer patients.
